Oxygen Therapy Equipment Market

Oxygen Therapy Equipment Market Outlook (2025 to 2035)

The worldwide oxygen therapy equipment market is expected to see tremendous growth from USD 4.2 billion in 2025 to USD 10.2 billion in 2035, growing at a CAGR of 8.9% during the forecast period. The growth is fueled by the rising incidence of chronic respiratory disorders, especially COPD and the growing geriatric population, and increased awareness of home-based oxygen therapy solutions.

Growing developments in technology across oxygen delivery solutions and the increasing proliferation of portable oxygen concentrators are also driving factors for sales expansion. With the need for effective respiratory care on the rise across the world, oxygen therapy is becoming more integrated into hospital and homecare settings.

Physicians are actively turning towards non-invasive respiratory care, particularly for post-operative treatment, COVID-19 recovery and management of chronic respiratory diseases. This is promoting investment in portable, easy-to-use devices that provide constant oxygenation with real-time monitoring capabilities.

The other significant driving force is a global rise in air pollution that has led to a rising number of respiratory illnesses in metropolitan areas. Along with this has been increased accessibility to healthcare within growing economies, and this has translated into the wider use of oxygen therapy as a vital intervention. Governments, as well as healthcare authorities, are further offering positive reimbursement schemes to finance the purchase of oxygen therapy machines.

In the meantime, innovation continues to be at the heart of competitive differentiation. Leading players are making efforts to enhance the ergonomics and portability of oxygen concentrators and cylinders, include digital control panels, and provide Bluetooth-compatible health monitoring systems. These features will be likely to drive consumer choice and encourage consistent use, especially among home-bound and elderly patients.

During the forecast period, the industry is set for consolidation as businesses increasingly seek collaboration with healthcare providers and home care services to broaden their reach. With respiratory health taking center stage on global health agendas, particularly in the wake of the COVID-19 pandemic, the oxygen therapy equipment market is set to continue its upward trend up to 2035

Key Metrics

Fact.MR Survey Results: Industry Dynamics Based on Stakeholder Perspectives

Stakeholder commentary from the oxygen therapy equipment marketplace indicates a dramatic worldwide shift to patient-focused, technology-driven solutions. Fact.MR's study discovered that 81% of healthcare professionals cite dependable home-based systems to help chronic care, with portable appliances preferred in North America and efficient, low-power systems prioritized in Europe.

Affordability and reliability across rural areas prioritized stakeholder concerns in the Asia-Pacific. Throughout geography, stakeholders are positioning their efforts according to changing demographics, ecological objectives, and regional health programs.

The utilization of cutting-edge technologies is redesigning competitive positions. North American vendors are placing app-enabled concentrators, with a noise-reduction focus in Europe and solar-backup emphasis in Asia-Pacific. Yet, challenges of a system-wide nature endure.

Disparate last-mile supply chain logistics, bureaucratic delays within Europe, and inadequately trained maintenance personnel in Asia continue to impede adoption on a mass scale. Despite these limitations, 78% of stakeholders intend to invest in oxygen flow systems with AI integration, region-specific priorities such as recyclable products in Europe and scalable models for rural deployment in Asia-Pacific.

Fact.MR analysis highlights that expansion will depend on digitalization, regulatory flexibility, and strategic partnerships. Dangers like supply chain turbulence and technology slowdown are still present, while the boardroom agenda has to be focused on crisis readiness, compliance drive, and customization of oxygen supply. Organizations focusing on intelligent, energy-saving, and geographically adaptable solutions have the potential to shape the future of respiratory therapy.

Shifts in the Market from 2020 to 2024 and Future Trends 2025 to 2035

During the years between 2020 and 2024, the oxygen therapy equipment market showed considerable growth driven mainly by the international health emergency that raised sensitivity toward respiratory disease. There was increased demand for portable oxygen concentrators and home-use oxygen therapy systems as hospitals and patients looked for convenient and easily accessible therapies.

Manufacturers aimed at enhancing device portability, noise reduction, and user-friendliness. Further, the expanded use of non-invasive oxygen therapy and wearable devices facilitated outpatient therapy and patient autonomy.

Between 2025 and 2035, the oxygen therapy equipment market will change with smart technology and evidence-based models of care. Technology will be networked, smarter, and smaller, and remote monitoring and control will be done through an app, making it easier to manage chronic respiratory disease. Diagnostics and predictive analytics based on artificial intelligence will optimize oxygen usage and delivery.

Green material application and sustainable production will also influence design. Personalized oxygen treatment, with machines conforming to specific respiratory patterns, will enhance patient outcomes and alleviate pressure on healthcare systems.

Comparative Market Shift Analysis 2020 to 2024 vs. 2025 to 2035

Country-wise Analysis

The USA

The USA oxygen therapy equipment market is anticipated to expand at 7.6% CAGR throughout the period under study. The oxygen therapy equipment market in the USA is likely to experience long-term growth owing to a widespread incidence of chronic respiratory diseases like COPD, asthma, and sleep apnea.

An aging population, combined with the sophisticated healthcare infrastructure in the country, enables the mass use of home-based oxygen therapy devices. Besides, good reimbursement structures and more healthcare expenditures facilitate accessibility among providers and patients. Technologies like portable oxygen concentrators and wearable oxygen devices are greatly driving sales penetration.

Also, greater awareness of the value of early treatment of respiratory diseases is fueling the growing demand. Major industry players are undertaking research and development efforts to make more efficient and smaller devices available.

Increasing interest in telemedicine and remote monitoring of patients is also making the integration of oxygen therapy systems at a broader scale into homecare models easier, helping the transition from hospital-centered to decentralized healthcare environments. Overall, the United States oxygen therapy equipment continues to be upbeat based on innovation, policy, and a mature healthcare consumer base that is complex.

UK

The UK oxygen therapy equipment market will register a 6.3% CAGR throughout the study period. Both healthcare modernization and greater emphasis on home healthcare service fuel the expansion of the oxygen therapy equipment market in the UK. Chronic respiratory diseases are among the foremost reasons for hospitalization, and therefore, national healthcare efforts are strengthening provisions for home oxygen therapy solutions.

The UK's National Health Service (NHS) has promoted self-management of chronic respiratory conditions proactively, helping expand the oxygen therapy equipment market. There is a clear trend toward light, portable oxygen devices enhancing patient mobility and quality of life. Integration of digital technology with oxygen delivery systems has become popular, allowing for more accurate dosage and monitoring outside the hospital environment.

Besides that, environmental and public health regulations to curtail smoking and air pollution have secondary benefits in boosting awareness and handling respiratory diseases. Players in the UK's oxygen therapy equipment market enjoy a secure regulatory setting that supports development while guaranteeing safety levels. Even though there are constraints within the healthcare budget, government commitment to managing chronic diseases means oxygen therapy continues as a priority level in both in-hospital and domiciliary management.

France

France's oxygen therapy equipment market will grow at a rate of 6.0% CAGR in the forecasting period. The French oxygen therapy equipment market is observing a uniform expansion in oxygen therapy equipment growth based on a higher incidence rate of chronic respiratory disease and growing older populations. National policies concerning health care are emphasizing stronger decentralization efforts in terms of healthcare, consequently accelerating demand for oxygen therapy solutions based on at-home usage.

Regional variations in the delivery of healthcare have also spurred the rising uptake of transportable oxygen equipment that allows continued care beyond institutional settings. Product design innovations such as improved battery life and reduced weight have resulted in more user-friendly devices suitable for patients leading active lives. The French system of care promotes partially reimbursed oxygen therapy in eligible conditions, which ensures continuity of use within urban and rural settings.

Effective partnerships among hospitals, device companies, and telehealth organizations are yielding improved patient outcomes and greater accessibility. Furthermore, environmental issues and rising levels of air pollution have created a greater societal interest in respiratory health, indirectly fueling the demand in the oxygen therapy equipment market. The industry trend is positive, with ongoing efforts towards technological integration and patient-centric care.

Germany

Germany's oxygen therapy equipment market is likely to expand at 6.5% CAGR over the study period. Germany boasts a strong healthcare system with high chronic disease management, which makes it a prominent stakeholder in the oxygen therapy equipment market. A rising population of older adults and a well-developed network of healthcare professionals provide strength to the oxygen therapy equipment market. Germany also boasts one of the highest rates of treatment and diagnosis of COPD in Europe, backing persistent demand for oxygen delivery systems.

Industry expansion is underpinned by robust insurance coverage of long-term therapy and forward-looking hospital discharge planning that encompasses home oxygen services. Technological advancements such as smart oxygen concentrators featuring real-time monitoring are becoming increasingly popular.

German patients also prefer energy-saving and noise-reducing oxygen systems, leading manufacturers to emphasize user comfort and device longevity. Compliance with European regulations also guarantees the introduction of high-quality equipment, enhancing patient confidence. Ongoing investment in research and regional distribution networks will most likely drive future growth and open up new opportunities for domestic and international suppliers.

Italy

The Italian oxygen therapy equipment market will grow at a 5.9% CAGR throughout the study period. Italy has moderate growth opportunities for the oxygen therapy equipment market, which is stimulated by the increasing burden of chronic respiratory disease and a progressively aging population. The national health system facilitates access to basic oxygen therapy, though regional variations in the delivery of services are challenging for uniform distribution of the devices.

Demand for portable oxygen concentrators is growing, particularly among older patients needing ambulatory oxygen therapy. Still, Italy's decentralized healthcare system sometimes hinders the adoption of newer technologies in all areas. Public hospitals and caregivers are slowly adopting digital oxygen delivery systems with embedded sensors to enable remote monitoring and prompt intervention.

Key players are concentrating on forging alliances with local distributors to enhance equipment availability and maintenance support. In spite of administrative barriers, the nation's strategic emphasis on aging and respiratory care guarantees steady, if paced, growth in the application of complex oxygen therapy equipment.

South Korea

The South Korean oxygen therapy equipment market is likely to expand at 6.7% CAGR throughout the research period. South Korea has high potential in the oxygen therapy equipment market, influenced predominantly by technology readiness and an aggressively aging population. Urbanization, as well as high air pollution rates, lead to an increased rate of respiratory diseases such as asthma and COPD. The government's efforts to digitalize healthcare and increase homecare services are driving the uptake of oxygen therapy solutions.

A significant consumer trend toward mobile and wearable oxygen therapy devices, particularly among city residents needing convenience and freedom of movement, exists. The adoption of oxygen therapy equipment with smartphone applications and remote monitoring platforms is consonant with South Korea's robust digital network infrastructure, supporting real-time patient interaction.

Nationwide health insurance further offers extensive support for the management of chronic diseases, making widespread access to necessary respiratory aids highly affordable. The increasing need for individualized healthcare and real-time sharing of data positions South Korea in the lead among digital oxygen therapy solutions, with the industry set for rapid growth.

Japan

The Japanese oxygen therapy equipment market is likely to expand at a 6.4% CAGR over the analysis period. The oxygen therapy equipment market in Japan is marked by consistent growth, driven by a long life expectancy and a significant morbidity burden of chronic respiratory diseases among the geriatric population. The universal healthcare system of the country enables patients to get early diagnosis and long-term treatment of respiratory diseases, favoring consistent demand for oxygen concentrators, cylinders, and other devices.

The oxygen therapy equipment market is also seeing a boost in the usage of small, quiet, and efficient oxygen therapy systems designed specifically for home care. Japan's focus on innovation in technology ensures a steady flow of next-generation devices with in-built smart technologies.

A focus on the quality of life of the elderly has spurred the growth of ergonomic and easy-to-use products that allow for independence. In addition, medical professionals are adopting AI-supported solutions for respiratory care, strengthening the position of oxygen therapy in long-term care strategies. Japan's early adoption of chronic disease treatment and health technology development places the country at the forefront.

China

The China oxygen therapy equipment market is anticipated to increase at 8.1% CAGR throughout the research period. China is the regional leader because of the convergence of high incidence of respiratory diseases, increased urbanization, and growing levels of air pollution.

The government's drive to enhance the healthcare infrastructure across urban and rural areas has hugely improved the accessibility of oxygen therapy equipment. Increased disposable income and expanding knowledge about the management of chronic diseases have further enhanced the adoption of this equipment.

Local manufacturers in China provide affordable, scalable oxygen therapy options. Technology upgrades and collaborations with digital health companies have brought forth smart oxygen concentrators that offer real-time monitoring.

The nation's growing proportion of older adults, coupled with the nation's heightened focus on home-based and community-level care, is set to fuel enduring demand. Regulatory reforms for the promotion of medical device innovation and quicker product approvals are contributing to a positive environment for both domestic and global industry participants.

Australia-New Zealand

The Australia-New Zealand oxygen therapy equipment market will be growing at 6.2% CAGR over the study period. Both Australia and New Zealand together provide a secure and mature oxygen therapy equipment market fueled by sophisticated healthcare infrastructures and intensive patient-focused care. The incidence of respiratory diseases like COPD and sleep apnea is increasing, providing a strong base for demand.

Both nations focus on home and community-based care, which bodes well for the portability and convenience of newer oxygen delivery systems. Government-sponsored healthcare programs cover long-term oxygen therapy, enhancing patients' access to equipment. Industry participants are investing in telehealth-ready solutions that are integrated within comprehensive respiratory care platforms.

Environmental issues, such as seasonal wildfires and air pollution, have also highlighted concerns about respiratory health, which contribute indirectly to equipment uptake. The regulatory framework supports innovation with a continuous inflow of technologically enhanced and safe products. Lifestyle-based delivery of healthcare will continue to propel the demand for adaptable and customized oxygen therapy solutions in the region.

Segment-wise Analysis

By Portability

Stationary oxygen devices account for a share of 61.4%, and portable oxygen devices will occupy 38.6% of the industry.

Stationary oxygen equipment is favored for its high oxygen output and feasibility of long-term use at lower costs. Patients needing continuous supplies of oxygen due to chronic respiratory diseases, such as COPD, pulmonary fibrosis, and emphysema, are generally accommodated with the use of stationary devices like home oxygen concentrators and liquid oxygen systems.

Philips Healthcare and Invacare are some of the major industry players that manufacture the Philips Respironics EverFlo and Invacare Platinum XL oxygen concentrators, which are the most used. Rightfully termed "workhorses," these devices are known for their reliability, low maintenance, and high flow rates suitable for long-term therapy, together with Linde Healthcare, which manufactures liquid oxygen systems and oxygen concentrators, thus enhancing the growth of the stationary segment by pursuing energy-efficient and user-friendly solutions.

Portable units in oxygen therapy devices are predicted to occupy a share of about 38.6% as they offer the highest degree of mobility and ease of handling. Oxygen therapy patients travel wherever they need to go, often with their portable oxygen concentrators (POCs) and portable cylinders. Such portable devices are especially useful for patients with severe respiratory problems who require supplemental oxygen for travel, exercise, or simply in daily life.

Inogen, a Singapore-based company with innovations such as the Inogen One G5 and O2 Concepts' Oxlife Independence Model, specializes in the development of lightweight, compact, and durable devices with prolonged battery life. Battery technology advances and miniaturization of components have increased portability and convenience attractiveness, thus making these portable devices capable of catering to busy patients' needs.

By Product

Oxygen Source Equipment is projected to have a 51.2% share in the oxygen therapy equipment market by the year 2025, while oxygen delivery devices will capture 48.8%.

Oxygen Source Equipment comprises the largest segment in the industry, contributing to the industry with more than 51% of its shares. In this segment are oxygen concentrators and liquid oxygen systems, which are important to ensure a continuous and dependable supply of oxygen. The oxygen concentrator works on the principle of filtration and concentration, separating oxygen from air within a home or clinical setting.

Among the leaders in this segment are Philips Health Care and Invacare, which use their Philips EverFlo and Invacare Platinum models. It is being widely used due to its efficiency and long-term cost-effectiveness, with a continuous capacity to deliver oxygen to patients with chronic respiratory diseases such as COPD or pulmonary fibrosis.

Linde Healthcare also offers liquid oxygen systems for patients who use more significant oxygen flow. The burgeoning demand for home healthcare services and long-term care for respiratory management will be a substantial contributor to the growth of this segment. At the same time, enhanced product reliability and reduced energy consumption levels will drive growth.

Oxygen Delivery Devices, which hold 48.8% of the share, are the link between the source equipment and the patient and thus ensure that the oxygen delivered is effective; it is subcategorized into devices for nasal cannulas, face masks, oxygen tubing, and non-invasive ventilation. The demand for delivery devices is derived from the rising number of patients on home oxygen therapy and the convenience, comfort, and efficacy of the method of delivery.

CareFusion (a part of BD) and Salter Labs manufacture various delivery devices, including the Salter 1600 nasal cannula, emphasizing patient comfort and optimizing the flow of oxygen. The rise of chronic respiratory disease prevalence, along with demand for portable solutions, has propelled innovation in this arena, including extended-use nasal prongs and high-flow oxygen masks aimed toward patients with more severe conditions.

Competitive Outlook

The oxygen therapy equipment market in 2025 is characterized by a mature yet highly responsive competitive environment. Core competition centers around the design and distribution of high-efficiency oxygen delivery systems, with differentiation driven by portability, automation, and long-term home care adaptability. While hospitals remain a key segment, the shift toward home-based and ambulatory oxygen therapy continues to reshape product design and vendor strategies.

Philips Healthcare and Inogen lead in innovation and sales penetration, with a strong emphasis on portable oxygen concentrators and user-friendly digital interfaces. Teleflex and Drägerwerk are notable for their presence in acute care, focusing on ventilator-integrated oxygen systems and smart flow regulation. Meanwhile, companies like Chart Industries and Linde Healthcare strengthen the industry with cryogenic and liquid oxygen solutions essential for both clinical and industrial-medical hybrid use.

Product innovation is increasingly focused on miniaturization, noise reduction, and energy efficiency. The integration of real-time oxygen saturation monitoring and app-based patient compliance tools has added layers of patient engagement and clinical data utility, enhancing both outcomes and product loyalty.

Strategic partnerships with remote monitoring platforms and acquisitions in the respiratory care segment are reshaping the positioning of industries. Players are leveraging data-driven respiratory analytics and wearable tech alliances to deliver holistic patient management beyond just oxygen supply.

Market Share Analysis by Company

Key Company Insights

Philips Healthcare (18-21%)

Philips dominates with a comprehensive line of concentrators and digital health integration, focusing on both clinical reliability and consumer usability for chronic respiratory patients.

Inogen, Inc. (15-18%)

Inogen’s stronghold lies in ultra-portable devices and direct-to-consumer strategies, enabling independence for patients while enhancing digital tracking of therapy compliance.

Teleflex Inc. (13-15%)

Teleflex supports hospitals with integrated respiratory portfolios, including advanced masks, humidifiers, and high-flow nasal systems for acute oxygen management.

Drägerwerk AG & Co. KGaA (10-12%)

Drägerwerk’s systems cater to critical care units, offering intelligent ventilation features and precision-controlled oxygen delivery in complex clinical settings.

Chart Industries, Inc. (8-10%)

Chart offers scalable oxygen delivery infrastructure, bridging hospital and home care with durable cryogenic storage and innovative low-pressure delivery systems.

Key Market Players

• Philips Healthcare
• Inogen, Inc.
• Teleflex Inc.
• Drägerwerk AG & Co. KGaA
• Chart Industries, Inc.
• Smiths Medical
• GE Healthcare
• Invacare Corporation
• Linde Healthcare
• Fisher & Paykel Healthcare Ltd.
• Taiyo Nippon Sanso Corporation